Diabetes in the Elderly: Retrospective Study

Diabetes Clinical Trial

Official title:

Diabetes Care in Nursing Home Residents

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01104168
• Other study ID #: IRB00035147
• Status: Completed
• Phase: N/A
• First received: April 9, 2010
• Last updated: November 12, 2013
• Start date: May 2010
• Est. completion date: December 2012

Study information

• Verified date: November 2013
• Source: Emory University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Diabetes is highly prevalent in the elderly, afflicting about 20% of older adults aged 65-75 years and 40% of adults >80years of age. Management of hyperglycemia is challenging in the geriatric population in long-term facilities. Numerous factors place hospitalized patients at increased risk for hyperglycemia including aging, sedentary life, stress of medical and surgical comorbidities, and changes in antidiabetic regimen. In addition, elderly patients often experience changes in their nutritional intake and organ dysfunction which increase the risk of hypoglycemic events.

There are only a few retrospective studies in elderly patients analyzing quality of diabetes care and glycemic control adjusted for medications and presence of co-morbidities in long-term care facilities. In addition, no randomized controlled trials have demonstrated benefits of glycemic control on clinical outcome, quality of life, and rate of acute metabolic complications (hyperglycemia and hypoglycemic events) in long-term care facilities.

Description:

The investigators will conduct a retrospective study to determine the prevalence of diabetes, comprehensively describe the management of diabetes, and to evaluate the impact of quality of care and glycemic control on clinical outcome in elderly subjects admitted to two large long-term care facilities: Grady Health System (GHS) and Veterans Administration Medical Center (VAMC) in Atlanta, Georgia between 1/01/08 to 12/31/08.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1409
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• ages 65+

• diagnosis of diabetes

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Diabetes

Locations

Country	Name	City	State
United States	A.G. Rhodes Homes	Atlanta	Georgia
United States	Bud Terrace Homes	Atlanta	Georgia

Sponsors (2)

Lead Sponsor	Collaborator
Emory University	Sanofi

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	prevalence of diabetes		1 year	No
Secondary	differences in glycemic control	determine differences in glycemic control as measured by mean daily blood glucose concentration between different insulin regimens	1 year	No
Secondary	evaluate the impact of quality of care and glycemic control on clinical outcome in elderly subjects		1 year	No